PDGFRA and Chronic Eosinophilic Leukemia, Not Otherwise Specified: BAY-43-9006 has also been reported to inhibit the oncogenic fusion protein of FIP1-like protein and PDGFRα that causes eosinophilic leukemia; the T674I mutant of this fusion protein is imatinib-resistant [31].